Literature DB >> 21282781

Neuropsychological changes and treatment response in severe depression.

Katie M Douglas1, Richard J Porter, Robert G Knight, Paul Maruff.   

Abstract

BACKGROUND: Impaired neuropsychological function and differences in facial emotion processing are features of major depression. Some aspects of these functions may change during treatment and may be useful in assessing treatment response, even at an early stage of treatment. AIMS: To examine early and later changes in neuropsychological functioning and facial emotion processing as potential markers of treatment response in major depression.
METHOD: In total, 68 newly admitted in-patients with a primary diagnosis of major depression and 50 healthy controls completed an assessment, including mood ratings, neuropsychological measures and facial emotion processing measures at three time points (baseline, 10-14 days and 6 weeks).
RESULTS: Pervasive neuropsychological impairment was evident at baseline in patients with depression compared with healthy controls. During 6 weeks of treatment, only simple reaction time, verbal working memory and the recognition of angry facial expressions showed differential change in those whose depression responded to treatment compared with treatment non-responders in the depression group. None of the measures showed a significant difference between treatment responders and non-responders at 10-14 days.
CONCLUSIONS: Despite significant impairment in neuropsychological functioning in the depression group, most measures failed to differentiate between treatment responders and non-responders at 10-14 days or at 6 weeks. Simple reaction time, verbal working memory and recognition of angry facial expressions may be useful in assessing response in severe depression but probably not at an early stage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282781     DOI: 10.1192/bjp.bp.110.080713

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

1.  Domain-specific impairment in cognitive control among remitted youth with a history of major depression.

Authors:  Amy T Peters; Rachel H Jacobs; Natania A Crane; Kelly A Ryan; Sara L Weisenbach; Olusola Ajilore; Melissa Lamar; Michelle T Kassel; Laura B Gabriel; Amy E West; Jon-Kar Zubieta; Scott A Langenecker
Journal:  Early Interv Psychiatry       Date:  2015-07-14       Impact factor: 2.732

2.  Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy.

Authors:  William H Theodore; Edythe A Wiggs; Ashley R Martinez; Irene H Dustin; Omar I Khan; Shmuel Appel; Pat Reeves-Tyer; Susumu Sato
Journal:  Epilepsia       Date:  2011-11-02       Impact factor: 5.864

3.  Neurocognitive predictors of treatment response to randomized treatment in adults with tic disorders.

Authors:  Amitai Abramovitch; Lauren S Hallion; Hannah E Reese; Douglas W Woods; Alan Peterson; John T Walkup; John Piacentini; Lawrence Scahill; Thilo Deckersbach; Sabine Wilhelm
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-11-15       Impact factor: 5.067

4.  Transdiagnostic mechanisms in depression and anxiety: The role of rumination and attentional control.

Authors:  Kean J Hsu; Courtney Beard; Lara Rifkin; Daniel G Dillon; Diego A Pizzagalli; Thröstur Björgvinsson
Journal:  J Affect Disord       Date:  2015-08-28       Impact factor: 4.839

5.  Earthquake Brain: Altered Recognition and Misclassification of Facial Expressions Are Related to Trauma Exposure but Not Posttraumatic Stress Disorder.

Authors:  Caroline J Bell; Helen C Colhoun; Chris M Frampton; Katie M Douglas; Virginia V W McIntosh; Frances A Carter; Jennifer Jordan; Janet D Carter; Rebekah A Smith; Leila M A Marie; Alex Loughlin; Richard J Porter
Journal:  Front Psychiatry       Date:  2017-12-12       Impact factor: 4.157

6.  Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients.

Authors:  Richard J Porter; Bernhard T Baune; Grace Morris; Amber Hamilton; Darryl Bassett; Philip Boyce; Malcolm J Hopwood; Roger Mulder; Gordon Parker; Ajeet B Singh; Tim Outhred; Pritha Das; Gin S Malhi
Journal:  BJPsych Open       Date:  2020-04-17

7.  Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders: study protocol.

Authors:  Katie M Douglas; Maree L Inder; Marie T Crowe; Jennifer Jordan; Dave Carlye; Cameron Lacey; Ben Beaglehole; Roger Mulder; Kate Eggleston; Katherine A Donovan; Christopher M A Frampton; Christopher R Bowie; Richard J Porter
Journal:  BMC Psychiatry       Date:  2022-02-14       Impact factor: 3.630

8.  Activation therapy for the treatment of inpatients with depression - protocol for a randomised control trial compared to treatment as usual.

Authors:  Ian R E Averill; Ben Beaglehole; Katie M Douglas; Jennifer Jordan; Marie T Crowe; Maree Inder; Cameron J Lacey; Christopher M Frampton; Christopher R Bowie; Richard J Porter
Journal:  BMC Psychiatry       Date:  2019-02-01       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.